** Shares of derivatives exchange operator CME Group CME.O rise as much as 4.9%, last up 3.9% at $251.05
** CME reports Q4 adjusted profit of $2.52/shr, beating Wall Street expectations of $2.44/shr, according to estimates compiled by LSEG
** Uncertainty around the U.S. election and economy, as well as geopolitics in the reported quarter, drove up demand for CME's hedging products
** "With volume growth across every asset class, we hit new records in interest rates, including U.S. Treasury and SOFR complexes, as well as in agricultural, foreign exchange and metals markets," CEO Terry Duffy says
** Q4 clearing and transaction fees, CME's major chunk of revenue, rose 4% to $1.23 billion
** Raymond James says better pricing in interest rate and equity index futures drove the Q4 beat
** CME stock rose 10.3% in 2024
(Reporting by Arasu Kannagi Basil in Bengaluru)
((ArasuKannagi.Basil@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。